Now, 🫀🦀 in Science Box 4 Abstract Session on new CardioOncology risk scores, moderated by Jennifer Cautela and Alex Lyon. #ESCCongress European Society of Cardiology JACC Journals #JACCO

ICYMI: Taking low-dose colchicine daily may slow the progression of clonal hematopoiesis, based on a subanalysis of the LoDoCo2 trial presented at ESC Congress 2025 & simultaneously published in #JACC.🔗 bit.ly/3Jwo7WG JACC Journals #ESCCongress

Incidence and risk factors of immune checkpoint inhibitor myocardial and muscle toxicity: a French nationwide study. Read more in #EHJ #ESCCongress European Society of Cardiology European Society of Cardiology Journals #Cardio-Oncology academic.oup.com/eurheartj/adva…

#PRADA_II trial #LBCT #ESCCongress #ARNi use in prevention of CV dysfunction during adjuvant #breastCA therapy: 📍Did not significantly attenuate ⬇️ in LVEF by #whyCMR 📍Reduced worsening of GLS & ⬇️ myocardial stress/injury, (by #troponin & #NTproBNP 📍Potential novel

❓Can #NTproBNP guide early cardioprotection in #cancer pts? 🧪#NTproBNP_Guide trial: #BreastCA & #lymphoma pts on #anthracyclines, randomized to #NTproBNP guided neurohormonal therapy 🆚 usual care 📍NT-proBNP–guided strategy was feasible & safe 📍Led to modest early LVEF

Yesterday At #ESCCongress Júlia Toste representing 🇵🇹 in a moderated poster session on prevention in #CardioOnc Sociedade Portuguesa de Cardiologia European Society of Cardiology

Complex Cardio-Oncology clinical cases, moderated by Teresa Lopez Fernandez and Giacomo Tini Melato #ESCCongress European Society of Cardiology JACC Journals Massimiliano Camilli Novi Yanti Sari

#PreciseDAPT cancer score as a tool to tailor DAPT strategy and balance ischemic vs bleeding risk. #ESCCongress #CardioOncology Mamas A. Mamas Felice Gragnano Mattia Galli Davide Capodanno Marco Valgimigli Dr Roxana Mehran

Now in Zagreb room. #ESCCongress Top 2025 papers published in EHJ in CardioOncology, HF and cardiac imaging. European Society of Cardiology European Society of Cardiology Journals Teresa Lopez Fernandez Massimiliano Camilli Novi Yanti Sari

Simultaneous publication during #ESCCongress Incidence, risk & prognostic factors of immune-checkpoint inhibitors cardio-myotoxicities: Results from the French National Health Data System ow.ly/r8Xs50WOxqM #EHJ

Join us at ESC Congress 2025 in Madrid for a joint session with ESMO - Eur. Oncology on harnessing innovation to reduce cardiovascular risk in cancer patients. Starting now! European Society of Cardiology Journals #ESCCongress

Outstanding session at #ESCCongress on AI in Cardio-Oncology led by Mariana Mirabel 🇫🇷 Mirabel Mariana From CMR & echocardiography to the HFA-ICOS risk score, AI is reshaping imaging, diagnosis & risk prediction—bringing precision medicine closer to daily practice. #ESCCongress

Can we predict cardiovascular complications in targeted cancer therapy?🫀 Prof Evandro de Azambuja, MD, PhD shares some of the clinical pearls at the #ESCCongress joint session with ESMO - Eur. Oncology: 📍Baseline CV risk assessment is essential 📍Different patients & treatments = different CV risk

Harnessing innovation to mitigate CV risk in patients with cancer‼️ Outstanding session about innovation in CardioOncology E de AzAmbuja M Mirabel A Lyon P Zagami #ESCCongress European Society of Cardiology JACC Journals Massimiliano Camilli Novi Yanti Sari

Simultaneous publication during #ESCCongress Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care ow.ly/C9Oh50WOJIz #EHJ

Our work led by Mustafa Al-jarshawi published yesterday following #ESCCongress presentation Abdominal aortic calcification a powerful predictor for cv mortality in cancer survivors ➡️academic.oup.com/ehjopen/advanc… Miguel Nobre Menezes MIЯVΛƬ #IC ༄ ｡° Sabha Bhatti MD Dr. Purvi Parwani Prof Kamlesh Khunti

Systematic review of 13 studies (n up to 342,226; follow-up 8–29.6y) found higher #CVD risk scores predict greater cancer risk (HR 1.16–3.71), while ideal CVH metrics link to lower risk (HR 0.49–0.95). 📖: jacc.org/doi/10.1016/j.… #JACCCardioOnc #CardioOnc #cvPrev @jacbvo

Excelente revisión sobre evaluación con ecocardiografia en el Síndrome del Carcinoide en el American Society of Echocardiography JASE onlinejase.com/article/S0894-…

🧬 New insights from iPSC models reveal how heart disease and cancer share genetic and metabolic pathways. A promising step toward personalized therapies in cardio-oncology. #CardioOnc #iPSCs Stanford CVI Javid Moslehi 📰tinyurl.com/ujvfb637

How to prevent heart failure AND cancer? #HFSA2025 Super session on multidisciplinary approach! You will need your oncologist, pharmacist + #CardioOnc #HFSAScientificStatement Dr Alana Ferrari Dr. Michelle Bloom Dharini Ramu Anne Blaes Anita Deswal